Table 2 Baseline characteristics
Variables | Incidence (%) or value |
|---|---|
Median age (range) | 58 years (21–83) |
Median follow-up periods (range) | 42.9 months (1.0–156.8) |
Gender | |
Male | 103 (74.1) |
Female | 36 (25.9) |
Histologic subtype | |
Conventional | 117 (84.2) |
Papillary | 16 (11.5) |
Chromophobe | 5 (3.6) |
Unclassified | 1 (0.7) |
Pathologic T stage | |
pT1a | 59 (42.4) |
pT1b | 34 (24.5) |
pT2 | 21 (15.1) |
pT3 | 20 (14.4) |
pT4 | 5 (3.6) |
N-stage | |
N0 or Nx | 129 (92.8) |
N+ | 10 (7.2) |
M stage | |
M0 or Mx | 130 (93.5) |
M1 | 9 (6.5) |
Nuclear grade | |
1 | 25 (18.0) |
2 | 58 (41.7) |
3 | 43 (30.7) |
4 | 13 (9.4) |